secwatch / observer
8-K filed May 12, 2023, 7:59 PM ET ticker BFRI CIK 0001858685
leadership confidence high sentiment negative materiality 0.75

Biofrontera CEO Monaco resigns; Luebbert takes over; Q1 revenue $8.7M, net loss $7.5M

Biofrontera Inc.

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Erica Monaco

Chief Executive Officer
BFRI · Biofrontera Inc.
Filed
May 12, 2023, 7:59 PM ET
Erica Monaco, Chief Executive Officer of the Company notified the Company’s Board of Directors that she intends to resign from the Company to pursue other opportunities.

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.98

Biofrontera Inc. reported first quarter ended March 31, 2023 results: revenue $8.7 million, EPS $(0.28) per share. Guidance reaffirmed.

Period
first quarter ended March 31, 2023
Revenue
$8.7 million
EPS
$(0.28) per share
Guidance
reaffirmed
Result
reported results
Exact text from the filing
Total revenues for the first quarter of 2023 were $8.7 million compared with $9.8 million for the first quarter of 2022.
View on SEC.gov
Executive change SEC 8-K Item 5.02 confidence 0.95

Erica Monaco departed as Chief Executive Officer at Biofrontera Inc..

Action
resign
Role
Chief Executive Officer
Exact text from the filing
Erica Monaco, Chief Executive Officer of the Company notified the Company’s Board of Directors that she intends to resign from the Company to pursue other opportunities.
View on SEC.gov

Browse all earnings releases →

Biofrontera Inc. filing history →

Source: SEC EDGAR
accession 0001493152-23-016502
Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.